Correlation Between G1 Therapeutics and Sangamo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both G1 Therapeutics and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining G1 Therapeutics and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between G1 Therapeutics and Sangamo Therapeutics, you can compare the effects of market volatilities on G1 Therapeutics and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in G1 Therapeutics with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of G1 Therapeutics and Sangamo Therapeutics.

Diversification Opportunities for G1 Therapeutics and Sangamo Therapeutics

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between GTHX and Sangamo is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding G1 Therapeutics and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and G1 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on G1 Therapeutics are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of G1 Therapeutics i.e., G1 Therapeutics and Sangamo Therapeutics go up and down completely randomly.

Pair Corralation between G1 Therapeutics and Sangamo Therapeutics

If you would invest  190.00  in Sangamo Therapeutics on September 19, 2024 and sell it today you would earn a total of  92.00  from holding Sangamo Therapeutics or generate 48.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy4.76%
ValuesDaily Returns

G1 Therapeutics  vs.  Sangamo Therapeutics

 Performance 
       Timeline  
G1 Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days G1 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical indicators, G1 Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Sangamo Therapeutics 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Sangamo Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain primary indicators, Sangamo Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

G1 Therapeutics and Sangamo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with G1 Therapeutics and Sangamo Therapeutics

The main advantage of trading using opposite G1 Therapeutics and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if G1 Therapeutics position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.
The idea behind G1 Therapeutics and Sangamo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities